FDA Calendar

Company Name Achaogen Inc.
Drug Name Plazomicin (NDA)
Event Name FDA decision on Plazomicin for the treatment of complicated urinary tract infections, and bloodstream infections
Event Date 06/25/2018
Outcome Date 06/26/2018
Outcome FDA approved ZEMDRI (plazomicin) on June 26, 2018, only for Complicated Urinary Tract Infections; Stock fell as much as 27%
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
Return to FDA Calendar